Acquiring Company
Rhelion Life Sciences
Acquired Company
Filament Health
Description
Rhelion Life Sciences Corp. has successfully acquired Filament Health Corp. This acquisition reinforces Rhelion's commitment to developing naturally derived psychedelic medicines. With this integration, Rhelion enhances its pharmaceutical capabilities and patent portfolio, positioning itself for continued growth in the life sciences sector.
Don't miss Rhelion Life Sciences's next move
Get an email the moment Rhelion Life Sciences makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Filament Health?
Filament Health was acquired by Rhelion Life Sciences, based in Toronto. The deal was reported on August 19, 2026. Rhelion Life Sciences Corp. is focused on advancing naturally derived psychedelic medicines through drug development and manufacturing. Rhelion Life Sciences is privately held and operates in Biotechnology.
When did Rhelion Life Sciences acquire Filament Health?
Rhelion Life Sciences's acquisition of Filament Health was reported on August 19, 2026. Rhelion Life Sciences Corp. has successfully acquired Filament Health Corp. This acquisition reinforces Rhelion's commitment to developing naturally derived psychedelic medicines. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Filament Health do?
Filament Health Corp. is dedicated to the development of botanical psychedelic drug candidates. The company offers pharmaceutical-grade products and has experience in regulatory matters with Health Canada and the FDA. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.